Literature DB >> 1190700

A population study of rheumatoid factor in Iceland. A 5-year follow-up of 50 women with rheumatoid factor (RF).

J Thorsteinsson, O J Björnsson, A Kolbeinsson, E Allander, N Sigfússon, O Olafsson.   

Abstract

The subject of this paper is a 5-year follow-up of 50 women found with Rose-Waaler Titre greater than or equal 1 : 10 or with a Acryl Fixation Titre greater than or equal 1 : 10 in a general health survey conducted in the Reykjavik area in 1968-1969. The average annual incidence of RA was 2.3 percent. Of four women who died during the follow-up period, three were amongst those with the highest titres. Two of the decreased had cancer mammae and one had lung cancer. Changes in RF-titres and New York Criteria are also discussed. It is suggested that RF-positives could be divided in three different riskgroups.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190700

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  9 in total

1.  Population study of the importance of rheumatoid factor isotypes in adults.

Authors:  T Jónsson; J Thorsteinsson; A Kolbeinsson; E Jónasdóttir; N Sigfússon; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

2.  Rheumatoid factor positivity increases all-cause and cancer mortality: a cohort study.

Authors:  Joong Kyong Ahn; Jiwon Hwang; Yoosoo Chang; Seungho Ryu
Journal:  Rheumatol Int       Date:  2017-05-17       Impact factor: 2.631

3.  The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.

Authors:  Ct Chou; Ht Liao; Ch Chen; Ws Chen; Hp Wang; Ky Su
Journal:  Biomark Insights       Date:  2007-05-03

4.  Clinical implications of IgA rheumatoid factor subclasses.

Authors:  T Jónsson; H Thorsteinsson; S Arinbjarnarson; J Thorsteinsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

5.  Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

Authors:  I Vallbracht; J Rieber; M Oppermann; F Förger; U Siebert; K Helmke
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

6.  A study of IgM rheumatoid factors in a middle-aged population of Northern Norway.

Authors:  J T Gran; A Johannessen; G Husby
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

7.  Rheumatoid Factor: A Novel Determiner in Cancer History.

Authors:  Alessio Ugolini; Marianna Nuti
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

8.  The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis.

Authors:  Mansoor Karimifar; Mansour Salesi; Ziba Farajzadegan
Journal:  Adv Biomed Res       Date:  2012-07-06

9.  The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.

Authors:  Münevver Serdaroğlu; Haşim Cakirbay; Orhan Değer; Sevil Cengiz; Sibel Kul
Journal:  Rheumatol Int       Date:  2008-04-17       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.